vimarsana.com
Home
Live Updates
FDA Makes Good on Its Promise to Regulate Laboratory-Develop
FDA Makes Good on Its Promise to Regulate Laboratory-Develop
FDA Makes Good on Its Promise to Regulate Laboratory-Developed Tests | Sheppard Mullin Richter & Hampton LLP
Yesterday, the Food & Drug Administration (“FDA” or “the Agency”) issued a highly anticipated – and highly controversial – final rule, which rolls out a four-year, five-stage plan that...
Related Keywords
United States ,
New York ,
American ,
,
Friends Of Cancer Research ,
Department Of Defense Do ,
Supreme Court ,
Public Health Service ,
Sheppard Mullin Richter Hampton ,
Veterans Health Administration ,
Food Drug Administration ,
Laboratory Developed ,
York State Clinical Laboratory Evaluation Program ,
College Of American Pathologists ,
American Clinical Laboratory Association ,
Academic Coalition For Effective Ldts ,
Us Food Drug Administration Jan ,
Sheppard Mullin Richter ,
Drug Administration ,
Laboratory Developed Tests ,
Verifying Leading Edge ,
Federal Food ,
Cosmetic Act ,
Public Health Service Act ,
Out Enforcement Discretion ,
Medical Device Reporting ,
Quality System ,
New York State ,
Clinical Laboratory Evaluation Program ,
Chevron Doctrine ,
Draft Guidance ,
Enforcement Policy ,
Certain In Vitro Diagnostic Devices ,
Immediate Public Health Response ,
Enforcement Policies ,
Tests During ,
Frequently Asked Questions ,
Press Release ,
Summary Testimony ,
Susan Van Meter ,
Health Subcommittee ,
House Energy ,
Commerce Committee ,
United States House ,
Discussion Paper ,
American Pathologists ,
Cancer Research ,
Academic Coalition ,
Current Good Manufacturing Practices ,
Pre Market Application ,